[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2025 Global Drugs for Short Bowel Syndrome Market Research by Type, End-Use and Region (COVID-19 Version)

August 2020 | 102 pages | ID: 2353E885ABFFEN
99Strategy

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Drugs for Short Bowel Syndrome market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:
  • Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
  • Chapter 2: Global Production & Consumption Market by Type and End-Use
  • Chapter 3: Europe Production & Consumption Market by Type and End-Use
  • Chapter 4: America Production & Consumption Market by Type and End-Use
  • Chapter 5: Asia Production & Consumption Market by Type and End-Use
  • Chapter 6: Oceania Production & Consumption Market by Type and End-Use
  • Chapter 7: Africa Production & Consumption Market by Type and End-Use
  • Chapter 8: Global Market Forecast by Type, End-Use and Region
  • Chapter 9: Company information, Sales, Cost, Margin, news etc.
  • Chapter 10: Market Competition by Companies and Market Concentration Ratio
  • Chapter 11: Market Impact by Coronavirus.
  • Chapter 12: Industry Summary
Market Segment as follows:

Key Companies
  • Ardelyx
  • Emmaus Life Sciences
  • GLyPharma Therapeutic
  • Merck
  • Naia Pharmaceuticals
  • Nutrinia
  • OxThera
  • Sancilio & Company
  • Takeda
  • Zealand Pharma
Key Types
  • GLP-2
  • Growth Hormone
  • Glutamine
  • Others
Key End-Use
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
This report can be dispatched within 24-48 Hours.
CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Drugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Drugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDrugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Drugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Drugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Figure Global Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Table Global Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Figure Global Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Global Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Figure Europe Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Table Europe Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Figure Europe Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Figure America Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Table America Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Figure America Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Table America Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table America Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Figure Asia Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Table Asia Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Figure Asia Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Table Oceania Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Figure Africa Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Table Africa Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Figure Africa Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Drugs for Short Bowel Syndrome Production Forecast
Figure Global Drugs for Short Bowel Syndrome Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Drugs for Short Bowel Syndrome Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Drugs for Short Bowel Syndrome Forecast by Type
Table Global Drugs for Short Bowel Syndrome Revenue by Type, 2020E-2025F (Million USD)
Figure Global Drugs for Short Bowel Syndrome Revenue Share by Type in 2025 (Million USD)
Table Global Drugs for Short Bowel Syndrome Production Volume by Type, 2020E-2025F (Volume)
Figure Global Drugs for Short Bowel Syndrome Production Volume Share by Type in 2025 (Volume)
8.3 Global Drugs for Short Bowel Syndrome Forecast by End-Use (2020E-2025F)
Table Global Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Drugs for Short Bowel Syndrome Forecast by Region (2020E-2025F)
Table Global Drugs for Short Bowel Syndrome Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Drugs for Short Bowel Syndrome Consumption Value Share by Region in 2025 (Million USD)
Table Global Drugs for Short Bowel Syndrome Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Drugs for Short Bowel Syndrome Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Ardelyx
  9.1.1 Ardelyx Profile
Table Ardelyx Overview List
  9.1.2 Ardelyx Products & Services
  9.1.3 Ardelyx Company Dynamics & News
  9.1.4 Ardelyx Business Operation Conditions
Table Business Operation of Ardelyx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Emmaus Life Sciences
  9.2.1 Emmaus Life Sciences Profile
Table Emmaus Life Sciences Overview List
  9.2.2 Emmaus Life Sciences Products & Services
  9.2.3 Emmaus Life Sciences Company Dynamics & News
  9.2.4 Emmaus Life Sciences Business Operation Conditions
Table Business Operation of Emmaus Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 GLyPharma Therapeutic
  9.3.1 GLyPharma Therapeutic Profile
Table GLyPharma Therapeutic Overview List
  9.3.2 GLyPharma Therapeutic Products & Services
  9.3.3 GLyPharma Therapeutic Company Dynamics & News
  9.3.4 GLyPharma Therapeutic Business Operation Conditions
Table Business Operation of GLyPharma Therapeutic (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Merck
  9.4.1 Merck Profile
Table Merck Overview List
  9.4.2 Merck Products & Services
  9.4.3 Merck Company Dynamics & News
  9.4.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Naia Pharmaceuticals
  9.5.1 Naia Pharmaceuticals Profile
Table Naia Pharmaceuticals Overview List
  9.5.2 Naia Pharmaceuticals Products & Services
  9.5.3 Naia Pharmaceuticals Company Dynamics & News
  9.5.4 Naia Pharmaceuticals Business Operation Conditions
Table Business Operation of Naia Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Nutrinia
  9.6.1 Nutrinia Profile
Table Nutrinia Overview List
  9.6.2 Nutrinia Products & Services
  9.6.3 Nutrinia Company Dynamics & News
  9.6.4 Nutrinia Business Operation Conditions
Table Business Operation of Nutrinia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 OxThera
  9.7.1 OxThera Profile
Table OxThera Overview List
  9.7.2 OxThera Products & Services
  9.7.3 OxThera Company Dynamics & News
  9.7.4 OxThera Business Operation Conditions
Table Business Operation of OxThera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Sancilio & Company
  9.8.1 Sancilio & Company Profile
Table Sancilio & Company Overview List
  9.8.2 Sancilio & Company Products & Services
  9.8.3 Sancilio & Company Company Dynamics & News
  9.8.4 Sancilio & Company Business Operation Conditions
Table Business Operation of Sancilio & Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Takeda
  9.9.1 Takeda Profile
Table Takeda Overview List
  9.9.2 Takeda Products & Services
  9.9.3 Takeda Company Dynamics & News
  9.9.4 Takeda Business Operation Conditions
Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Zealand Pharma
  9.10.1 Zealand Pharma Profile
Table Zealand Pharma Overview List
  9.10.2 Zealand Pharma Products & Services
  9.10.3 Zealand Pharma Company Dynamics & News
  9.10.4 Zealand Pharma Business Operation Conditions
Table Business Operation of Zealand Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Drugs for Short Bowel Syndrome Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Drugs for Short Bowel Syndrome Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Drugs for Short Bowel Syndrome Sales Volume by Companies, 2015-2020E (Volume)
Table Global Drugs for Short Bowel Syndrome Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Drugs for Short Bowel Syndrome Market Concentration Ratio in 2020E
Figure America Drugs for Short Bowel Syndrome Market Concentration Ratio in 2020E
Figure Asia Drugs for Short Bowel Syndrome Market Concentration Ratio in 2020E
Figure Oceania Drugs for Short Bowel Syndrome Market Concentration Ratio in 2020E
Figure Africa Drugs for Short Bowel Syndrome Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON DRUGS FOR SHORT BOWEL SYNDROME INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 DRUGS FOR SHORT BOWEL SYNDROME INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Table Global Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Table Global Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Global Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Table Europe Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Table Europe Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)
Table America Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Table America Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Table America Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table America Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Table Asia Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Table Asia Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Table Oceania Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Table Oceania Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Drugs for Short Bowel Syndrome Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Drugs for Short Bowel Syndrome Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Drugs for Short Bowel Syndrome Revenue by Type, 2015-2020 (Million USD)
Table Africa Drugs for Short Bowel Syndrome Production Volume by Type, 2015-2020 (Volume)
Table Africa Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Drugs for Short Bowel Syndrome Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Drugs for Short Bowel Syndrome Consumption Volume by Region, 2015-2020 (Volume)
Table Global Drugs for Short Bowel Syndrome Revenue by Type, 2020E-2025F (Million USD)
Table Global Drugs for Short Bowel Syndrome Production Volume by Type, 2020E-2025F (Volume)
Table Global Drugs for Short Bowel Syndrome Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Drugs for Short Bowel Syndrome Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Drugs for Short Bowel Syndrome Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Drugs for Short Bowel Syndrome Consumption Volume by Region, 2020E-2025F (Volume)
Table Ardelyx Overview List
Table Business Operation of Ardelyx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Emmaus Life Sciences Overview List
Table Business Operation of Emmaus Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GLyPharma Therapeutic Overview List
Table Business Operation of GLyPharma Therapeutic (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Naia Pharmaceuticals Overview List
Table Business Operation of Naia Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nutrinia Overview List
Table Business Operation of Nutrinia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table OxThera Overview List
Table Business Operation of OxThera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sancilio & Company Overview List
Table Business Operation of Sancilio & Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Overview List
Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zealand Pharma Overview List
Table Business Operation of Zealand Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Drugs for Short Bowel Syndrome Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Drugs for Short Bowel Syndrome Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Drugs for Short Bowel Syndrome Sales Volume by Companies, 2015-2020E (Volume)
Table Global Drugs for Short Bowel Syndrome Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Drugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Drugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDrugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Drugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Drugs for Short Bowel Syndrome Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Drugs for Short Bowel Syndrome Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Figure Global Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
Figure Global Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Figure Europe Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
Figure Europe Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Figure America Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
Figure America Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Figure Asia Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
Figure Asia Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Figure Oceania Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
Figure Oceania Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Drugs for Short Bowel Syndrome Revenue Share by Type in 2020 (Million USD)
Figure Africa Drugs for Short Bowel Syndrome Production Volume Share by Type in 2020 (Volume)
Figure Africa Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Drugs for Short Bowel Syndrome Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Drugs for Short Bowel Syndrome Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Drugs for Short Bowel Syndrome Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Drugs for Short Bowel Syndrome Revenue Share by Type in 2025 (Million USD)
Figure Global Drugs for Short Bowel Syndrome Production Volume Share by Type in 2025 (Volume)
Figure Global Drugs for Short Bowel Syndrome Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Drugs for Short Bowel Syndrome Consumption Value Share by Region in 2025 (Million USD)
Figure Global Drugs for Short Bowel Syndrome Consumption Volume Share by Region in 2025 (Volume)


More Publications